For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211117:nRSQ7106Sa&default-theme=true
RNS Number : 7106S Smith & Nephew Plc 17 November 2021
SMITH & NEPHEW PLC
17 November 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.
On 16 November 2021, Smith+Nephew was notified that the following awards of
US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the
"Company") vested under the Smith & Nephew Global Share Plan 2010.
1. FINAL VESTING ON 13 NOVEMBER 2021 OF A CONDITIONAL SHARE AWARD
MADE UNDER THE GLOBAL SHARE PLAN 2010:
The award was granted under the Global Share Plan 2010 on 13 November 2018.
One third of the shares vested on 13 November 2019, a further third vested on
13 November 2020 and the final third vested on 13 November 2021. A number of
Shares were sold to cover taxation obligations arising on the vesting of the
awards.
The following relates to individuals included in the below notification:
Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Final vesting of a Conditional Share Award granted on 13 November 2018 under
the Smith & Nephew Global Share Plan 2010.
Date of Transaction 2021 - 11 - 15
Place of Transaction London Stock Exchange (XLON)
Name Director / PDMR Price Volume Aggregated information Total Ordinary Share Holding following the transaction * Total Ordinary Share Holding as a % of the Company's ISC following the
transaction *
(Position)
Skip Kiil PDMR £13.105 18,351 (of which 7,247 were sold and 11,104 retained) N/A Single Transaction 23,306.12693 ordinary shares 0.00263%
(President Orthopaedics)
* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.
2. SKIP KIIL - SALE OF ORDINARY SHARES
Reason for the notification
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Smith & Nephew plc
LEI 213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code ISIN: GB0009223206
Nature of the transaction Sale of ordinary shares.
Date of Transaction 2021 - 11 - 16
Place of Transaction London Stock Exchange (XLON)
Name (Position) Director / PDMR Price (£) Volume Aggregated information Total Ordinary Share Holding following the transaction * Total Ordinary Share Holding as a % of the Company's ISC following the
transaction *
Skip Kiil PDMR 13.124612 23,306 N/A Single Transaction 0.12693 ordinary shares 0.00000%
(President Orthopaedics)
* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFSVLDLDLIL